Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,894 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,867 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06497660 | Effect of Neoadjuvant Chemotherapy on Cardiac Function of Perioperative Patients With Breast Cancer and New Strategies for Anesthesia | unknown | Phase 4 | 496 | Fujian Medical University Union HospitalOTHER | 1 | Mar 4, 2025 | clinicaltrials |
| NCT06428682 | Role of TXA in Patients Undergoing Breast Free Flap Reconstruction | unknown | Phase 4 | 100 | University of VirginiaOTHER | 1 | Jun 5, 2024 | clinicaltrials |
| NCT06406127 | Effect of Alpha Lipoic Acid on Chemotherapy Induced Neurological Changes in Breast Cancer Patients | unknown | Phase 4 | 92 | Ain Shams UniversityOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT06300099 | Dexamethasone Versus Dexmedetomidine as Adjuncts to Serratus Anterior Plane Block | unknown | Phase 4 | 126 | Al-Azhar UniversityOTHER | 0 | Mar 12, 2024 | clinicaltrials |
| NCT04904653 | The Effectiveness of Hemopatch® in the Reduction of Post-surgical Serous Drainage | unknown | Phase 4 | 118 | Instituto de Investigación Hospital Universitario La PazOTHER | 1 | Mar 6, 2024 | clinicaltrials |
| NCT05949333 | Reducing Neutropenia Incidence With Pegfilgrastim Administration on Day 3 After Chemotherapy(NEUTHREE) | unknown | Phase 4 | 100 | Eunseong Medical Foundation Good GANG-AN HOSPITALOTHER | 1 | Feb 23, 2024 | clinicaltrials |
| NCT05949424 | OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults(OPTI-DOSE) | unknown | Phase 4 | 30 | University Medical Center GroningenOTHER | 1 | Nov 29, 2023 | clinicaltrials |
| NCT05861635 | The Study of Vidicizumab Combined With Tirelizumab in the Treatment of Breast Cancer With Low HER2 Expression | unknown | Phase 4 | 42 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | May 17, 2023 | clinicaltrials |
| NCT05033769 | Assessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast Cancer(AIRE) | unknown | Phase 4 | 82 | Institut fuer FrauengesundheitOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT05036005 | Neoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label (NeoON)(NeoON) | unknown | Phase 4 | 108 | Institut fuer FrauengesundheitOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT05809024 | Select the Appropriate Population for Adding CDK4/6i to Neoadjuvant Endocrine Therapy | unknown | Phase 4 | 100 | Yongsheng WangOTHER | 1 | Apr 12, 2023 | clinicaltrials |
| NCT05302336 | AC vs TC in Patients With HR-positive, HER2-negative Early Breast Cancer | unknown | Phase 4 | 402 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Apr 14, 2022 | clinicaltrials |
| NCT05291910 | Inetetamab Combined With Anti-PD-1 Monoclonal Antibody and Albumin-Bound Paclitaxel for HER2+ Metastatic Breast Cancer | unknown | Phase 4 | 70 | Chinese Academy of Medical SciencesOTHER | 1 | Mar 23, 2022 | clinicaltrials |
| NCT05191914 | Clinical Study of Fulvestrant Combined With Chidamide in the Treatment of Hormone Receptor-positive Advanced Breast Cancer Resistant to CDK4/6 Inhibitors | unknown | Phase 4 | 20 | Liaoning Cancer Hospital & InstituteOTHER | 0 | Jan 14, 2022 | clinicaltrials |
| NCT05131841 | Cipterbin Combined With Vinorelbine in the Treatment of HER2-positive MBC | unknown | Phase 4 | 60 | Zhejiang Cancer HospitalOTHER | 1 | Nov 23, 2021 | clinicaltrials |
| NCT04137640 | Palbociclib + Letrozole Versus Epirubicin + Cyclophosphamide and Sequential Docetaxel as Neoadjuvant Chemotherapy | unknown | Phase 4 | 152 | Shengjing HospitalOTHER | 1 | Jul 20, 2021 | clinicaltrials |
| NCT04029467 | Effect of Dexmedetomidine on the Duration of Pain Control in ESP Block for Breast Surgery | unknown | Phase 4 | 44 | Lebanese American UniversityOTHER | 1 | Feb 23, 2021 | clinicaltrials |
| NCT03738527 | SEroma Reduction pOst MAstectomy "SEROMA Study"(SEROMA) | unknown | Phase 4 | 100 | Hamilton Health Sciences CorporationOTHER | 1 | Feb 21, 2021 | clinicaltrials |
| NCT04261179 | Study Comparing Lymphoseek® vs. Albumin Nanocolloid in Head and Neck, Melanoma and Breast Cancer(SENTINELSEEK) | unknown | Phase 4 | 30 | Anna CrucetaOTHER | 1 | Feb 20, 2020 | clinicaltrials |
| NCT04182568 | Nab-paclitaxel Compared With Docetaxel Followed by Anthracyclines and Cyclophosphamide in the Neoadjuvant Breast Cancer | unknown | Phase 4 | 100 | Xijing HospitalOTHER | 1 | Dec 2, 2019 | clinicaltrials |
| NCT04116021 | The Analgesic Efficacy of the Pectoral Nerves Block Versus Local Anesthetic Infiltration After Mastectomy(PECS) | unknown | Phase 4 | 50 | Hôpital du ValaisOTHER | 0 | Oct 4, 2019 | clinicaltrials |
| NCT03123770 | Efficacy and Safety of Neoadjuvant DC-T in Breast Cancer Patients(ESNDBCP) | unknown | Phase 4 | 384 | Zhejiang UniversityOTHER | 1 | Apr 10, 2019 | clinicaltrials |
| NCT02590315 | Tomosynthesis Versus Digital Mammography in a Population-based Screening Program(ProteusDonna) | unknown | Phase 4 | 92,000 | Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica PiemonteOTHER | 1 | Jan 31, 2019 | clinicaltrials |
| NCT03799679 | Albumin-Bound Paclitaxel Followed by Epirubicin in Combination With Cyclophosphamide in Triple Negative Breast Cancer | unknown | Phase 4 | 60 | Fudan UniversityOTHER | 1 | Jan 10, 2019 | clinicaltrials |
| NCT03676114 | Effect of Perioperative Low Dose Ketamine on Postoperative Recovery in Patients Undergoing Breast Cancer Surgery | unknown | Phase 4 | 100 | Han YuanOTHER | 1 | Sep 21, 2018 | clinicaltrials |
| NCT03199560 | Tilmanocept vs Sulfur Colloid in Sentinel Lymph Node Biopsy | unknown | Phase 4 | 86 | Memorial Health University Medical CenterOTHER | 1 | Aug 24, 2018 | clinicaltrials |
| NCT03591549 | Fulvestrant in Metastatic Breast Cancer | unknown | Phase 4 | 30 | Assiut UniversityOTHER | 0 | Jul 23, 2018 | clinicaltrials |
| NCT03465202 | Association of Capecitabine Pharmacokinetics and Toxicity With Aging | unknown | Phase 4 | 100 | Newcastle-upon-Tyne Hospitals NHS TrustOTHER | 0 | Mar 14, 2018 | clinicaltrials |
| NCT02982148 | Methylene Blue Intradermal Injection for Sentinel Lymph Node Biopsy for Breast Cancer Patients | unknown | Phase 4 | 352 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Dec 5, 2016 | clinicaltrials |
| NCT02781259 | Selective Lymph Node Dissection Using Fluorescent Dye in Node-positive Breast Cancer | unknown | Phase 4 | 150 | Samsung Medical CenterOTHER | 1 | Sep 20, 2016 | clinicaltrials |
| NCT02903524 | Doxorubicin Hydrochloride Liposome Injection Combination With Cyclophosphamide vs Pirarubicin Combination With Cyclophosphamide in Patients With Locally Advanced Breast Cancer | unknown | Phase 4 | 300 | Hebei Medical University Fourth HospitalOTHER | 1 | Sep 16, 2016 | clinicaltrials |
| NCT01427400 | The Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast Reconstruction(Botox) | unknown | Phase 4 | 128 | University of British ColumbiaOTHER | 1 | Jul 29, 2016 | clinicaltrials |
| NCT02766530 | Integrated Positron Emission Tomography Magnetic Resonance (PET/MR) of Breast Cancer | unknown | Phase 4 | 40 | National Taiwan University HospitalOTHER | 1 | May 9, 2016 | clinicaltrials |
| NCT01956409 | Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer Diagnosis | unknown | Phase 4 | 80 | National Taiwan University HospitalOTHER | 1 | Feb 4, 2016 | clinicaltrials |
| NCT02207361 | Paclitaxel in Combination With Carboplatin Versus Paclitaxel Plus Epirubicin in Metastatic Breast Cancer | unknown | Phase 4 | 120 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Dec 22, 2015 | clinicaltrials |
| NCT02627248 | Neoadjuvant Chemotherapy With or Without Huaier Granule in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery | unknown | Phase 4 | 200 | Shandong UniversityOTHER | 1 | Dec 10, 2015 | clinicaltrials |
| NCT02615457 | Huaier Granule in Treating Women With Triple Negative Breast Cancer | unknown | Phase 4 | 300 | Shandong UniversityOTHER | 1 | Nov 26, 2015 | clinicaltrials |
| NCT02612870 | Sienna+® Injection Time Study 4 Arms(Sentimag02) | unknown | Phase 4 | 40 | Kantonsspital BadenOTHER | 1 | Nov 24, 2015 | clinicaltrials |
| NCT02142790 | Weekly and Every 3 Week Administration of Paclitaxel Liposome Injection in Metastatic Breast Cancer | unknown | Phase 4 | 120 | Nanjing Luye Sike Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 22, 2014 | clinicaltrials |
| NCT00413491 | National Screening in Denmark With MR Versus Mammography and Ultrasound of Women With BRCA1 or BRCA2 Mutations(MR BRCA) | unknown | Phase 4 | 300 | Danish Breast Cancer Cooperative GroupOTHER | 1 | May 20, 2014 | clinicaltrials |
| NCT01956890 | 18F-FLT Positron Emission Tomography and Magnetic Resonance Imaging of the Breast | unknown | Phase 4 | 80 | National Taiwan University HospitalOTHER | 1 | Oct 16, 2013 | clinicaltrials |
| NCT00030758 | Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer | unknown | Phase 4 | 816 | Anglo Celtic Cooperative Oncology GroupOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT01849380 | Neoadjuvant ECS Versus ECF in Local Advanced Breast Cancer | unknown | Phase 4 | 240 | Shandong UniversityOTHER | 1 | May 8, 2013 | clinicaltrials |
| NCT01597999 | Benefits of Breast MRI for Predicting of Histopathologic Cell Type of Small Breast Cancer | unknown | Phase 4 | 60 | Mahidol UniversityOTHER | 1 | Jan 23, 2013 | clinicaltrials |
| NCT01698164 | Multi-centre Clinical Trial on Hormone Replacement Treatment in China | unknown | Phase 4 | 1,200 | Peking Union Medical College HospitalOTHER | 1 | Oct 2, 2012 | clinicaltrials |
| NCT01216254 | Clinical Trial Comparing Outcomes of Breast Conserving Operations With Classic v High-frequency Electrocoagulation | unknown | Phase 4 | 150 | Medical University of GdanskOTHER | 1 | Jan 31, 2012 | clinicaltrials |
| NCT01049295 | Omega-3 Fatty Acids and Chemotherapy-induced Neuropathy and Inflammation in Breast Cancer | unknown | Phase 4 | 52 | Tehran University of Medical SciencesOTHER | 1 | Nov 1, 2011 | clinicaltrials |
| NCT00647075 | Yunzhi as Dietary Supplement in Breast Cancer(YUNZHI-BC) | unknown | Phase 4 | 60 | Hospital Clinic of BarcelonaOTHER | 1 | Dec 15, 2010 | clinicaltrials |
| NCT01072318 | Extended Adjuvant Treatment With Letrozole in Breast Cancer Who Complete 5 Years of Toremifene(LEXTOP) | unknown | Phase 4 | 495 | Korean Breast Cancer Study GroupOTHER | 1 | Feb 22, 2010 | clinicaltrials |
| NCT00912938 | Evaluate the Relationship of Bone Remodeling Markers for Skeletal Complications in Metastatic Breast Cancer Patients | unknown | Phase 4 | 237 | Korean Breast Cancer Study GroupOTHER | 1 | Feb 17, 2010 | clinicaltrials |
Data updated 23 days agoSource updated Mar 4, 2025source: clinicaltrials